Industry Leader Joins Ichor Therapeutics as Chief Medical Officer

Posted on Posted in Uncategorized

Syracuse, NY – Ichor Therapeutics, a pre-clinical contract research organization, recently announced the appointment of Cornelis (Cees) Hendrik Wortel MD, PhD to the position of Chief Medical Officer (CMO). Dr. Wortel brings over 25 years of experience to Ichor, having worked as a senior (bio) pharmaceutical executive for early stage and established companies, both nationally […]

Ship of Theseus, LLC initiates lifespan study at Ichor

Posted on Posted in Uncategorized

Philadelphia, PA and LaFayette, NY – Today, Ship of Theseus, LLC, a bioengineering company that focuses on stem cell therapies for aging and age-associated disease, announces the initiation of a murine lifespan study to be conducted at Ichor Therapeutics, Inc. This work will inform new targets for therapeutic intervention in aging. Ship of Theseus was […]

Ichor unveils orally bioavailable antibody-like scaffold in ACS Biochemistry

Posted on Posted in Uncategorized

LaFayette, NY – Today, a landmark biotechnology was published for the first time in the peer-reviewed journal ACS Biochemistry. The article, “RPtag as an orally bioavailable, hyper stable epitope tag and generalizable protein binding scaffold,” describes a foundational technology that could have huge implications in drug discovery, diagnostics, and clinical antibody therapy.

Ichor CEO delivers keynote at TriBeta Northeast Conference

Posted on Posted in Uncategorized

Fredonia, NY: Today, the State University of New York at Fredonia hosted the Northeastern District-3 Conference for TriBeta, the Biology Honor Society. Kelsey Moody, CEO at Ichor Therapeutics, delivered the keynote address. In the address, he discussed Ichor’s humble beginnings in a West Syracuse apartment, and encouraging pre-clinical results from the company’s age-related macular degeneration […]

Ichor to present double feature at Undoing Aging Conference in Berlin

Posted on Posted in Uncategorized

LaFayette, NY – The 2018 Undoing Aging Conference, co-hosted by SENS Research Foundation and Michael Greve’s Forever Healthy Foundation, is a scientific forum focused on the cellular and molecular repair of age-related damage. It provides a platform for leading researchers from around the world to share their work in stem cells, senescent cells, immunotherapies, biomarkers, […]

Ichor named 2018 Business of the Year finalist

Posted on Posted in Uncategorized

Read the original article here LaFayette, NY – Each year Syracuse’s economic development counsel and chamber of commerce, CenterState CEO, recognizes Central New York businesses for their outstanding achievements during the past year. Ichor Therapeutics, Inc. has been selected as a finalist for 2018. “We feel very privileged for being selected as a finalist,” remarked […]

Kelsey Moody on leadership: Be coachable and hire people who can teach you

Posted on Posted in Uncategorized

Link to original article By Stan Linhorst StanLinhorst@gmail.com, syracuse.com Kelsey Moody was a medical student at Upstate Medical University when he landed a $540,000 research grant and set up his own pharmaceutical research company. “After we had cleared our first million dollars in funding for the company, I had to choose: Did I want to finish my medical […]

Ichor featured in News Channel 9 segment

Posted on Posted in Uncategorized

Please click here for video. LAFAYETTE, N.Y. (WSYR-TV) – One Central New York start-up is looking to start human trials on their solution to macular degeneration– a disease that’s a leading cause of vision loss for over 10 million Americans. Ichor Therapeutics, based in LaFayette, is looking to make a name for itself. “There’s no […]